Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

281
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
281
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

578
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
578
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

250
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
250
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

548
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
548
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

639
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
639
How Data are Classified: Categorical Data01:11

How Data are Classified: Categorical Data

45.2K
A variable, usually notated by capital letters such as X and Y, is a characteristic or measurement that can be determined for each member of a population. Data are the actual values of variables. They may be numbers, or they may be words. Datum is a single value.
Data are classified based on whether they are measurable or not. Categorical data cannot be measured; instead, it can be divided into categories. For example, if Y denotes a person's party affiliation, some examples of Y include...
45.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-Driven Predictions of Diastereoselectivity in Crystallization-Induced Diastereomer Transformations.

Organic letters·2026
Same author

Data Science and High-Throughput Spectroelectrochemistry-Guided Interrogation of Sulfonate Anions for OMIECs.

Journal of the American Chemical Society·2026
Same author

Assessment of Complementary Catalysts in an Uncharted Enantioselective Reaction of Sulfondiimines.

Journal of the American Chemical Society·2026
Same author

Best Practices and Considerations for Applying Multiple Linear Regression in Organic Chemistry Research.

The Journal of organic chemistry·2026
Same author

Synergizing Chemical and AI Communities for Advancing Laboratories of the Future.

ACS central science·2026
Same author

Markovnikov hydroamination of terminal alkenes by phosphine redox catalysis.

Nature·2026
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs
08:25

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs

Published on: January 17, 2020

7.8K

Transferable enantioselectivity models from sparse data.

Simone Gallarati1,2, Erin M Bucci2, Abigail G Doyle3

  • 1Department of Chemistry, University of Utah, Salt Lake City, UT, USA.

Nature
|February 11, 2026
PubMed
Summary
This summary is machine-generated.

Developing new catalysts for enantioselective reactions is challenging due to limited data. This study introduces a new descriptor strategy to predict catalyst performance for novel reactions and optimize existing ones.

More Related Videos

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

Related Experiment Videos

Last Updated: Feb 13, 2026

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs
08:25

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs

Published on: January 17, 2020

7.8K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

Area of Science:

  • Organic Chemistry
  • Computational Chemistry
  • Catalysis

Background:

  • Optimizing enantioselectivity in new reactions is difficult, especially with limited data on catalyst-substrate interactions.
  • Existing statistical models struggle with mechanistically complex transformations and sparse datasets.

Purpose of the Study:

  • To develop a novel descriptor generation strategy for predicting catalyst performance in enantioselective reactions.
  • To enable modeling of reactions with diverse ligand and substrate types, addressing data scarcity.

Main Methods:

  • Generated descriptors accounting for changes in the enantiodetermining step based on catalyst/substrate identity.
  • Collected data on enantioselective nickel-catalyzed C(sp3)-couplings.
  • Trained statistical models using features from proposed transition states and intermediates.

Main Results:

  • Developed models applicable to unseen ligands and reaction partners.
  • Successfully optimized poorly performing examples within a substrate scope.
  • Demonstrated a strategy for quantitatively transferring knowledge from sparse data to new chemical spaces.

Conclusions:

  • The new descriptor strategy effectively models complex enantioselective reactions.
  • This approach streamlines catalyst and reaction development by enabling prediction across diverse chemical spaces.
  • Facilitates knowledge transfer from limited data to novel applications in asymmetric catalysis.